SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 134 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,770,000 | +73.7% | 212,150 | -7.7% | 0.19% | +69.9% |
| Q3 2015 | $1,595,000 | -23.2% | 229,891 | +8.7% | 0.11% | -27.1% |
| Q2 2015 | $2,076,000 | +377.2% | 211,422 | +330.5% | 0.16% | +416.7% |
| Q1 2015 | $435,000 | -86.4% | 49,106 | -86.6% | 0.03% | -85.9% |
| Q4 2014 | $3,206,000 | +108.7% | 366,013 | +64.1% | 0.21% | +113.0% |
| Q3 2014 | $1,536,000 | – | 223,047 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
| Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
| Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
| MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
| Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
| TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
| Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
| GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
| Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |